{
  "inputs": {
    "scripts/cta_report_common.py": "5c8e25b79e39404ef099ff5960a3f775e4e22ce03bddc760ccd190df54fa7c13",
    "scripts/build_cta_candidate_evidence.py": "848c8952f442c4874018931ae47c4580eae8fc78345db3b3e5b1b720251d4261",
    "scripts/collect_cta_candidate_tumors.py": "f92215ab44c387083da7937014509a28646f4688eabbc7db2f3b6a568f38dee5",
    "oncoref/gene_knowledge.py": "e0cefcd2ea1ae560a293845eca726c185efe27990c850ba495a42d53c2d3fa11",
    "oncoref/cta_selection_policy.py": "ce6e72ecf3661636e2f95ae7a67e8e9d112153aaa84c97cf349258a6c4039e9e",
    "oncoref/cta_decision_flow.py": "569083d7ad10b5cc82ddeb3ca6e3c3c34231e3fc4d5f920e7d9a602f89e2d0a4",
    "oncoref/cta_representatives.py": "477d3ba50d9b327b32a504799c66f40e79b7d2070e8224775380cf1942c0eff8",
    "oncoref/data/gene-knowledge.json": "b230ceda243bc77c5ca926abe394d3aa9400b1e174561bcd5dee744fac95305f",
    "oncoref/data/gene-knowledge-updates.json": "2625613f9a935d98bc4dd9297e2eda4b0d0a4b83199bdcabac9a70860507ec36",
    "oncoref/data/cancer-type-registry.csv": "6365e0f51f87cf6d6eeb573fd229b0b4748da4b9b76aa882e4764a1e28ca7a35",
    "scripts/cta_evidence_assets/named-candidate-report.md": "256c7e2d7ba5c4c2a7604d4715f657ce4210ae266de446ffff39c49c2adfa9a8",
    "docs/audits/cta-selection-20261028/protein-group-classifications.csv.gz": "b4fd7001e6e302133b439b3e21c65277bf6b2b53e2826724350866b624c400aa",
    "docs/audits/cta-candidate-evidence-20261108/inputs/PRAMEF18.xml.gz": "091291ae63ee70253812f5aad4b81ed1d4f9d383a2a1ff9f484fd790b034c563",
    "docs/audits/cta-candidate-evidence-20261108/inputs/SSU72L1.xml.gz": "d94dc892dc1a70a93a76587141d1c785f30c1ca794ef6cc722e4cf4f0400198f",
    "docs/audits/cta-candidate-evidence-20261108/inputs/SSU72L2.xml.gz": "b62be198129a7fc5ed5d6c54650f28b03bf7dd83b91328b5d6e12851123e8a90",
    "docs/audits/cta-candidate-evidence-20261108/inputs/SSU72L3.xml.gz": "9376e267f83b73b0a14989f24a6d080f1bfbf2a4c19c4dfd362960a0f38b4a09",
    "docs/audits/cta-candidate-evidence-20261108/inputs/SSU72L4.xml.gz": "364b7b7b21ac19fcf9b763956b70d5062e328ed447963e9b5285a5ac93f18d57",
    "docs/audits/cta-candidate-evidence-20261108/inputs/SSU72L5.xml.gz": "0eb2e65dc1903ce4955b98da85d322ad01721c34265dc135ac5244f3e88e35a1",
    "docs/audits/cta-candidate-evidence-20261108/inputs/Sod1-mouse-primer-targets.json": "3409885eaaad6e8b02da1c0f04c42f0148535a07e5baeaf521d41bf46860ad49",
    "docs/audits/cta-candidate-evidence-20261108/inputs/TEDDM1.xml.gz": "3fbbc288593365a9fdff7fdf11c1fdaf9e0fc97c56b0a42e41571584e83ab7f3",
    "docs/audits/cta-candidate-evidence-20261108/inputs/TMEM269.xml.gz": "cf1271de38a2c0c410d60ba8bbe8b15f9e1af93d14597f58ad7384bc95e2632c",
    "docs/audits/cta-candidate-evidence-20261108/inputs/TRIM75.xml.gz": "d81d07f2f11cc31dcd4b78132ecac9dddb63ec9f5becda2d19dd1932bfc530ba",
    "docs/audits/cta-candidate-evidence-20261108/inputs/UBTFL1-primer-check.json": "ef60d2bc752917a05a44a2625e37207dd07adca2ed51aab576d228f02b52a9fb",
    "docs/audits/cta-candidate-evidence-20261108/inputs/UBTFL1.cdna.json": "b170d41d05227bdcf57d38392682e2ffe977e46a998aec40bea44ce2c1f2820a",
    "docs/audits/cta-candidate-evidence-20261108/inputs/UBTFL1.xml.gz": "25455c6c5cc662521873a617b2ebc7c80799dc4ebacdf92caf7944d58c28a1ea",
    "docs/audits/cta-candidate-evidence-20261108/inputs/XM_021185540.2.gb.gz": "2a983614a183be406f8c5706b3fabe7d2ef7f567b1b82c972ac860c51fd5b1cc",
    "docs/audits/cta-candidate-evidence-20261108/inputs/candidates.json": "64d6de008785be6ce8be8140218de803a85e8ea1de622b530bd4b52573a7dd70",
    "docs/audits/cta-candidate-evidence-20261108/inputs/hpa-current-normal-rna.csv": "e9017e39c550a88b4cd2335f004bb3f4c9978c84851dea8f9bd188f3ae2dfe58",
    "docs/audits/cta-candidate-evidence-20261108/inputs/hpa-tumor-ihc.csv": "b4c477d792df7ddf5b2e853b1c2ec7fd2c0aa44dd2eaea2eae720fa3f0fdff2e",
    "docs/audits/cta-candidate-evidence-20261108/inputs/hpa-tumor-rna.csv": "0a750917fc41ae148586daad4b6317d4e589d95fea8112aaab42d1ce61a097e4",
    "docs/audits/cta-candidate-evidence-20261108/inputs/matrix-provenance.json": "e2ca41ed38f85c60bee9ceb73d2bfced3dad2be06638d6a678bf9b24a93e9d9b",
    "docs/audits/cta-candidate-evidence-20261108/inputs/normal-contexts.csv": "042105ca915747cc6c360b23baf958ec2d5d5cdae9202bec2dfe5bddca212332",
    "docs/audits/cta-candidate-evidence-20261108/inputs/released-candidate-facts.csv": "acb85d858a14e3a5c5329dbd17bad6a532d392cba7f81e0c35b1c956024cb1db",
    "docs/audits/cta-candidate-evidence-20261108/inputs/sample-qc-errors.json": "f50331fa19eba4ee6d51b7d1c8e022ed895d459e7e3e8f949671a6db268be5ce",
    "docs/audits/cta-candidate-evidence-20261108/inputs/sample-qc.csv.gz": "91c1932bcb8981a6a043ae5c81f563e818a5118d3f012111630cec162f1362a7",
    "docs/audits/cta-candidate-evidence-20261108/inputs/taf11-like-scope.csv": "b6a73f03df114005166890d34fd63b93690ea22806948752a7810a295461b2ec",
    "docs/audits/cta-candidate-evidence-20261108/inputs/tumor-coverage.csv": "d7465d1759f73381c6d21070c29503a0abea81cb1468d2696dad18e18a740465",
    "docs/audits/cta-candidate-evidence-20261108/inputs/tumor-samples.csv.gz": "16e4ccd3cfcb7e240502c6da2abe0b7bd01101b0caeff3d43f617d719dcad609",
    "docs/audits/cta-candidate-evidence-20261108/inputs/uniprot-20261108.json.gz": "504fcf1d7080ed5099a49ee957bd3b49ed2de08df67c80183d3a13892c90292b"
  },
  "outputs": {
    "candidates.csv": "0cc46c2725fab1c7a3455fb2433e6c96cf29d39a942fb01ca94380689007272f",
    "classification-changes.csv": "f91ae195e72e17442e5119edc83ac72270be2c033d5a39e3af0981c97ae95e4f",
    "decision-flow.json": "51c64d77b7cfa0556fa02bbb697185b0acffa56eaa6549fe24dead28a21f2030",
    "decision-flow.png": "aeedb0d73e03b1484afd25b7a99cd6c0ac7fc7bf9dbf37d7bd5558615753c544",
    "decision-flow.svg": "8b97ec2a70a6a95cc9b5a0691a4b5932ce11d3ec774abf7326271ab8bc1b288e",
    "index.md": "83d41cabafcb71576f115e9e46a896a22d53a0fcf669a01b2e04e7fe1ea8ac3e",
    "report.html": "2aa0f5a72dd7b8556078f56aaa90b0ecf59171114b6f34fa41b6f352316eed49",
    "ssu72-admission.csv": "e32234dcd7e1ec8690d08a757118a6d01311ae255b64d56d1e05ef8684c13aca",
    "ssu72l2-cohorts.csv": "a897dfc320682d9cdd66f7b48a8ba1316c3c2b799190ce141147ea9b1e74672c",
    "ssu72l2-positive-samples.csv": "d83d0831e11909d29d21c28355c82065b275d42625db8d77f5a57ba82ce6d880",
    "ssu72l2-samples.png": "cecfa866480f0e9d796ffbfe5861b4af57a50be67c384b87e63d2a175a3b0cfb",
    "ssu72l2-samples.svg": "e6acf978ab325aca8801ac17b9123548906447bb7861b4101a7f29f7b456abd6",
    "summary.json": "e32d28e7fbd0d8dd1eb78edfe82305d0f732bdf89d14452b0d6b21ca891af15e",
    "table.html": "00e1197cb5269a1bb4e408936e7b5fe93ef4f9a5bae1de2381f60bcd0818c897",
    "tumor-cohort-prevalence.csv": "68cca4107e82cf26f8806eeb5056eca4c439cc3a7125839c0a9a4da75fed571a",
    "tumor-prevalence.png": "5d3f63623669d2ce99e2ee098ce8dd172628fc23df83bc949f9aeec20630412b",
    "tumor-prevalence.svg": "fb40182f04b487f9ad4d4e18f1bc759c8d302fad562ec5a74c109a30066055da",
    "tumor-samples.csv.gz": "1449ff6569dc3a2658b130d2304aa39d5ec912352a3ab55998ea3375c9a52736",
    "uniform-gene-decisions.csv.gz": "03c9716c4ce16b60e52ab87fd8bc8f6df5765794dca7f2ad27f7f1c4d0f0b832",
    "uniform-protein-decisions.csv.gz": "41b739191c8c7a32e1515695e163409ba56bdfd221a2a2287d0cd8dba75c32d8"
  }
}